Skip to search formSkip to main contentSkip to account menu

NGX-4010

Known as: NGX 4010, NGX4010 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Objectives:To evaluate the efficacy, safety, and tolerability of repeated NGX-4010 treatments in the open-label extension phase… 
2012
2012
Background The objective of this study was to assess the safety, tolerability, and preliminary efficacy of NGX-4010, a capsaicin… 
2011
2011
BackgroundPost-herpetic neuralgia (PHN) is a common type of neuropathic pain that can severely affect quality of life. NGX-4010… 
2011
2011
Results: During the studies, 302 NGX-4010 and 250 control (capsaicin, 0.04% wt/wt) patients were using at least 1 systemic… 
Highly Cited
2010
Highly Cited
2010
OBJECTIVES To assess the efficacy, tolerability, and safety of NGX-4010, a high-concentration capsaicin dermal patch (capsaicin… 
2010
2010
BackgroundPostherpetic neuralgia (PHN) is a painful and difficult to treat complication of acute herpes zoster. Current treatment… 
Highly Cited
2009
Highly Cited
2009
NeurogesX Inc is developing NGX-4010, a rapid-delivery dermal patch application system that contains high-concentration trans…